Inventor
Jose Andres SALMERON GARCIA
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
C07KPeptides30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
Y02ATechnologies for adaptation to climate change7%
C12NMicroorganisms or enzymes3%
C12YEnzymes3%
PatentTitleYear
12,534,505Activatable interleukin-2 polypeptides and methods of use thereof202612,275,769Activatable interleukin 12 polypeptides and methods of use thereof202511,981,716Activatable interleukin-2 polypeptides and methods of use thereof202411,739,132Separation moieties and methods of use thereof202311,535,658Activatable interleukin-2 polypeptides and methods of use thereof202211,453,710Activatable interleukin 12 polypeptides and methods of use thereof202211,453,720Anti-TIGIT antigen-binding proteins and methods of use thereof202211,352,403Activatable interleukin-2 polypeptides and methods of use thereof202211,186,644Anti-neuropilin antigen-binding proteins and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2022Patents assigned to POTENZA THERAPEUTICS INC (2)· patent assignee history
2021–2026Based in US· patent location history
2022–2026Patents assigned to WEREWOLF THERAPEUTICS INC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WEREWOLF THERAPEUTICS INC | 7 | 2022–2026 |
| POTENZA THERAPEUTICS INC | 2 | 2021–2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2026 |